Rosetta Genomics (NASDAQ: ROSG) announces the commercial launch of OncoGxOne, Admera Health’s next-generation sequencing (NGS) panel that detects a vast ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE